Industry n/a · SIC —

Algernon Health Inc.

AGNPF

Watch

Latest revenue

as of

Latest net income

as of

Net margin

as of

9.1
of 10

ActaClear Score

Strong
#396 of 4096 in industry
+0.0 · 2d
Profitability·25%
Growth·15%
Value·20%
8.4
Quality·20%
Momentum·20%
9.8

Computed from 5 years of SEC fundamentals + latest market data, ranked within industry (4096 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 7, 2026.

Community sentiment

Where do you think AGNPF is heading?

1 month
6 months
12 months
5 years
Sign in free to vote and see community sentiment

Price · 5Y

+21.3% / yr 1.6 pts / yr vs S&P 500 161.5% total
Compare:

Live market

delayed ≤15 min
$0.34
6.62%
Market cap
Enterprise value
P/E (trailing)
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$0.38
52-wk low
$0.02
Beta
Shares out

5-year trend

No quarterly data ingested yet for this company.

About AGNPF

Business description and risk factors will appear here once AGNPF's latest filing is fully ingested.

Earnings tracker

Not enough quarterly history for AGNPF yet to draw an earnings tracker.

Industry trend

Industry · SIC

No data yet for industry average

Your notes

Keep private notes on AGNPF — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

No insider transactions on file for AGNPF in the last 12 months.

Source: SEC Form 4 filings. Backfill runs nightly.

Who owns AGNPF

No institutional holdings on file for AGNPF yet.

Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).

Top questions investors are asking

Coming once AGNPF's latest filing finishes processing.

Investor sentiment
No votes yet
0 this week · 0 total

Sign in to vote. Votes use 7-day half-life decay.

What matters about AGNPF?
Tap any that apply. Aggregates show what other investors flag.

Sign in to tap. 7-day half-life decay.